Cookies on this site

In its first major refresh since its establishment in 2018, the BioEscalator is delighted to welcome five leading University of Oxford academics and innovators to its Management Board. The Management Board provides a source of expertise for BioEscalator tenants and works to enhance research at the University by building strong links with small life sciences companies.

Five board members

Peter Callow is a seasoned finance executive with extensive international experience in financial management, strategic planning, and leadership.

Professor Catherine Green OBE is Head of the Clinical Biomanufacturing Facility at Nuffield Department of Medicine and Associate Professor in Chromosome Dynamics at the Centre for Human Genetics. She played a key role in developing the Oxford/AstraZeneca Covid-19 vaccine.

Professor Bethan Psaila is an Associate Professor of Haematology and Cancer Research at MRC Weatherall Institute of Molecular Medicine; she is also Co-founder of a blood malignancies company and BioEscalator tenant Alethiomics.

Professor Molly Stevens DBE is John Black Professor of Bionanoscience at the Institute of Biomedical Engineering and the Department of Physiology, Anatomy & Genetics and research director for biomedical materials at Imperial College London.

Professor Krina Zondervan is Head of the Nuffield Department of Women's & Reproductive Health, Professor of Reproductive and Genomic Epidemiology, and Co-Director of the Endometriosis Care Centre.

 

Read the full story on the BioEScalator website. 

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.